NCT00089531View on ClinicalTrials.gov

Candidate HIV Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 2, 2004

Study Completion Date

January 15, 2008

Conditions
HIV Infections
Interventions
DRUG

VRC-HIVDNA016-00-VP

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00089531 - Candidate HIV Vaccine | Biotech Hunter | Biotech Hunter